Kenneth Kearns

Kenneth Kearns practices at Estrella Center in Albuquerque, New Mexico.

Kenneth Kearns' NPI, 1598148223, was assigned on June 30, 2015. Kenneth Kearns holds Arizona license 33789.

Kenneth Kearns' primary practice is Estrella Center, at 101 Sun NE Ave, Albuquerque, NM 87109 in Bernalillo County. The practice phone is (623) 932-2282.

Kenneth Kearns' primary practice is Estrella Center in Albuquerque, New Mexico. The medical group on file is Primary Care Physicians Group. Dmand AI also links Kenneth Kearns to 1 more physician office, 1 group practice or clinic, 1 home health agency, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kenneth Kearns practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Kenneth Kearns' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Kenneth Kearns' licenses on file in 2 states: Arizona and Montana.

CMS data shows 318 Medicare services from Kenneth Kearns across 4 procedure codes in 2024, for 31 Medicare patients. Medicare paid $35,289 for them. Every service was in an office.

CMS counts 31 Medicare patients who saw Kenneth Kearns in 2024. The largest group is 85 and over, with 14 patients. 74% of them have high blood pressure, and 68% have arthritis. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kenneth Kearns' median patient age at 88, with 63% women.

In 2024, Kenneth Kearns wrote 589 Medicare Part D claims for 37 patients. 85% of them were for generic drugs. CMS names the drug for 421 of them, across 18 drugs with 11 or more claims each, at $34,889 in total drug cost. In 2023, CMS named 834 claims across 33 drugs.

Kenneth Kearns accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Kenneth Kearns from 1 drug or device company from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. Integra LifeSciences Corporation paid the most, $265.